ePT--the Electronic Newsletter of Pharmaceutical Technology, Jan 3, 2013 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

ePT--the Electronic Newsletter of Pharmaceutical Technology, Jan 3, 2013
News
Mylan Recalls Painkiller Pills due to Risk of Higher Dosage
By Adeline Siew, PhD
Mylan issued a voluntary recall of three lots of the painkiller tablets hydrocodone bitartrate and acetaminophen.
GSK Partners with Vodafone for Vaccinations
By Stephanie Sutton
GlaxoSmithKline has formed a partnership with Vodafone to use mobile technology to help vaccinate more children against common infectious diseases in Africa.
FDA Approvals of NMEs and BLAs Increased in 2012
By Patricia Van Arnum
Additional approvals in December have helped to outpace a recent high set in 2011.
BASF Extends Offer Period to Acquire Pronova BioPharma
By Adeline Siew, PhD
BASF extended its offer period to acquire Pronova BioPharma, a producer of omega-3 fatty acids.
Week of December 31, 2012: Mylan, Orion Enter Into Comtan Settlement Agreement; Takeda, Amylin Terminate Agreement to Codevelop and Commercialize Compounds for Obesity; and More
Mylan, Orion Enter Into Comtan Settlement Agreement; Takeda, Amylin Termination Agreement to Codevelop and Commercialize Compounds for Obesity; and More.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
26%
Attracting a skilled workforce
29%
Obtaining/maintaining adequate financing
13%
Regulatory compliance
32%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Click here